Rare diseases
Investigational molecules
Locations
Hohenrainstrasse 24, 4133
Santhera Pharmaceuticals (Schweiz) AG focuses on neuromuscular disease research centred on Duchenne muscular dystrophy, with related interest in Becker muscular dystrophy. Its clinical activity includes studies in boys affected by progressive muscle weakness and functional decline, reflecting a therapeutic emphasis on conditions with substantial unmet need in paediatric and adolescent care.
Research in this area is directed toward long-term management of disease-related complications and the preservation of muscle function in muscular dystrophy.
Santhera Pharmaceuticals (Schweiz) AG runs clinical trials in conditions such as Duchenne muscular dystrophy, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
